Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.81 -0.05 (-0.62%)
As of: Oct 23, 2026 · 3:58 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) Price to Earnings (2022 - 2023)

Updated

Aspire Biopharma Holdings' Price to Earnings came in at 966.52 for Q4 2023, down 81.8% from 5319.23 a year earlier but up 21.0% from the prior quarter.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) Price to Earnings (2022 - 2023) Analysis & Trends

Going back to Q2 2022, Aspire Biopharma Holdings' Price to Earnings data covers 7 quarters.

  • Going back by year, Price to Earnings was 5319.23 in FY2022.
  • The five-year range for quarterly Price to Earnings is 798.95 (Q3 2023) to 1024610.20 (Q2 2022).
  • Year-over-year, Price to Earnings has declined for three consecutive quarters.
  • Business Quant data shows ASBP's Price to Earnings at 798.95 (Q3 2023), 1040.55 (Q2 2023) and 2874.77 (Q1 2023) in the three quarters before Q4 2023.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 966.52
Sep 30, 2023 798.95
Jun 30, 2023 754.74
Mar 31, 2023 2,395.64
Dec 31, 2022 4,432.69
Sep 30, 2022 13,139.71
Jun 30, 2022 853,841.83
API Access

Aspire Biopharma Holdings, Inc. Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=ASBP&period=max&api_key=YOUR_API_KEY